Skip to main content

Day: January 22, 2024

CREDIT AGRICOLE SA: Crédit Agricole S.A. announces the acquisition of a minority stake in Worldline

Montrouge, January 22, 2024Crédit Agricole S.A. announces the acquisition of a minority stake in Worldline Crédit Agricole S.A. announces that it has acquired a 7% minority interest in Worldline S.A. This investment is building upon the strategic partnership between Crédit Agricole Group and Worldline S.A., for which the signing of a binding agreement was announced in July 2023. It is intended to strengthen this partnership to create a major player in the French merchant payment services market. In addition to the strategic partnership, this transaction demonstrates Credit Agricole Group’s intention to support Worldline’s development and implementation of its strategy as a key European payment services provider. Through this transaction, Crédit Agricole Group is reaffirming confidence in its partner: a strong franchise, leading-edge...

Continue reading

Sandoz announces agreement to acquire CIMERLI® business from Coherus, strengthening position in US market

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASECIMERLI®*, a ranibizumab biosimilar, is interchangeable with LUCENTIS®** (ranibizumab-injection) for all approved indications Acquisition strengthens Sandoz ophthalmology portfolioBasel, January 22, 2024 – Sandoz, the global leader in generic and biosimilar medicines, has signed an agreement to acquire the US biosimilar ranibizumab CIMERLI®* (ranibizumab-eqrn) from Coherus BioSciences, Inc. for an upfront cash purchase payment of USD 170 million. This is inclusive of a biologics license application, product inventory, ophthalmology sales and field reimbursement talent, as well as access to proprietary commercial software. Keren Haruvi, President Sandoz North America, said: “I am pleased that we can add another high-value product to the growing Sandoz...

Continue reading

WISeKey and Xapo Bank Join Forces to Showcase WISe.ART Digital and Physical Art Exhibition in Gibraltar

Exhibition features a collaboration with SO/ Sotogrande Spa & Golf Resort Hotel Geneva, Switzerland , Jan. 22, 2024 (GLOBE NEWSWIRE) —WISeKey and Xapo Bank Join Forces to Showcase WISe.ART Digital and Physical Art Exhibition in Gibraltar Exhibition features a collaboration with SO/ Sotogrande Spa & Golf Resort Hotel Geneva, Switzerland – January 22, 2024: WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a global leader in cybersecurity, digital identity, and Internet of Things (IoT) solutions operating as a holding company, today announced that its subsidiary WISe.ART, a leader in the field of digital art, has partnered with Xapo Bank, a trusted financial institution, on a groundbreaking art exhibition. The exhibition is set to open on January 25, 2024, and will merge cutting-edge technology...

Continue reading

Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in $170 Million Upfront All Cash Deal

– Transaction aligns to Coherus’ strategic focus on oncology –– Conference call Monday, January 22, 2024, at 8:30 a.m. Eastern Time – REDWOOD CITY, Calif., Jan. 22, 2024 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced it has entered into an agreement to divest its CIMERLI® (ranibizumab-eqrn) ophthalmology franchise, inclusive of CIMERLI and its supporting commercial infrastructure, to Sandoz for upfront, all-cash consideration of $170 million plus an additional amount for CIMERLI product inventory and subject to customary working capital adjustments at the closing date. This divestiture includes Coherus’ CIMERLI biologics license application, ophthalmology sales and select field reimbursement teams, CIMERLI product inventory on hand, and access to proprietary commercial software. “Since entering...

Continue reading

20240122 – Worldline welcomes Crédit Agricole as a long-term shareholder

Worldline welcomes Crédit Agricole as a long-term shareholder Paris La Défense, 22 January 2024. Worldline welcomes the announcement that was disclosed this morning by Crédit Agricole of its c. 7% stake in its share capital as a long term shareholder. Crédit Agricole is an important commercial partner of Worldline and the two groups have entered into a long-term strategic partnership in merchant services, which was announced in H1 2023. This alliance would enable the creation of a joint-venture with the ambition of becoming a major player in the French market, leveraging on the technological performance and innovation capabilities of Worldline, combined with the commercial strength and distribution networks of Crédit Agricole, further supporting Worldline strategy as a leading player in the European payment market. The stake in Worldline...

Continue reading

REE Completes U.S. Certification of Full-by-Wire Vehicles and Begins Customer Deliveries of its P7-C Electric Truck

REE’s P7-C electric commercial truckREE’s P7-CREE’s P7-C can be up fit with almost any body designREE’s P7-C Chassis CabThe P7-C chassis cabREE’s P7-C Driving on RoadsREE’s P7-C has become the first full by-wire vehicle to be certified in the U.S.REE’s P7-C is the first fully by-wire truck to achieve U.S. FMVSS and EPA certifications Customer deliveries of demonstration trucks has begun P7-C vehicles are eligible for US federal tax credit of up to $40,000 per vehicle and are expected to be eligible for over $100,000 of incentives per vehicle with additional state creditsTEL AVIV, Israel, Jan. 22, 2024 (GLOBE NEWSWIRE) —  REE Automotive Ltd. (Nasdaq: REE) (“REE” or the “Company”), an automotive technology company and provider of full by-wire...

Continue reading

Perseus Mining announces intention to make takeover bid for OreCorp Ltd

Perth, Jan. 22, 2024 (GLOBE NEWSWIRE) — PERSEUS MINING ANNOUNCES INTENTION TO MAKE TAKEOVER BID FOR ORECORP LIMITEDPerth, Western Australia/January 22, 2024/ Perseus Mining Limited (ASX/TSX: PRU) (Perseus or the Company) announces its intention to make an off-market takeover offer (Offer) for all of the issued shares in OreCorp Limited (ASX: ORR) (OreCorp) that it does not already own (OreCorp Shares) for cash consideration of A$0.55 per OreCorp Share.Full details of the Perseus Offer will be contained within a bidder’s statement that is expected to be lodged with ASIC, provided to OreCorp and released to the ASX prior to the end of January 2024.This Offer to OreCorp’s shareholders is valued at a 4.0% premium1 to the currently implied value of a takeover offer made by Silvercorp Metals Inc (Silvercorp) (Silvercorp Takeover),...

Continue reading

Gildan Comments on Violations of US Antitrust Law by Browning West

Browning West’s rapid accumulation of Gildan shares last month violated the US Hart-Scott-Rodino Act Browning West illegally acquired stake in order to take control of the Gildan Board and reinstall former Gildan CEO by requisitioning a special shareholders’ meeting Illegal share acquisitions demonstrate short-term, reckless, and poorly planned nature of Browning West’s campaign Gildan plans to take all appropriate actions to protect shareholders MONTREAL, Jan. 21, 2024 (GLOBE NEWSWIRE) — Gildan Activewear Inc. (GIL: TSX and NYSE) (“Gildan” or the “Company”) today announced that it has learned that Browning West, LP (“Browning West”) accumulated shares in violation of the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”) as part of its misguided campaign to reinstall Glenn Chamandy as CEO of Gildan. The...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.